Gland Pharma seeks pitches from investment bankers to go public

Gland Pharma, which is owned 74% by the Chinese major, is seeking a valuation of $3 billion, which is more than twice that of the valuation it was bought in September 2017.

from Healthcare/Biotech-Industry-The Economic Times https://ift.tt/2NyGrwn
via IFTTT